Sanofi buys US biotech company Principia for $3.4bn
It's the second-largest pharmaceutical acquisition in 2020 after Gilead bought Forty Seven in March
17 August 2020 - 17:46
Paris — Sanofi agreed to acquire US biotech company Principia Biopharma for about $3.4bn as the French drugmaker pivots towards innovative therapies to spur growth under new CEO Paul Hudson.
The all-cash deal will see Sanofi taking full control of the company, which focuses on treatments for multiple sclerosis and a range of autoimmune disorders, according to a statement on Monday...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.